With Equal Access, African Americans with Non-del17p Multiple Myeloma Have Superior Overall Survival, but del17p Still Carries Poor Prognosis across Race: A VA Study
Blood (2019) 134 (Supplement_1): 4388.
Currently there are no citedby results. Try again later.
